SCHEMBL22988923

SCHEMBL22988923

c1ccc2c(c1)oc1ccc(-c3nc(-c4ccc5cc(-n6c7ccc8cccc9sc%10cccc%11ccc6c(c%11%10)c7c89)ccc5c4)nc4c3sc3ccccc34)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22989136 0.97
SCHEMBL22989134 0.92
SCHEMBL22989024 0.92 PMM2 (0.30)
SCHEMBL22989207 0.92 MAPK9 (0.32)
SCHEMBL22988921 0.91
SCHEMBL22988927 0.90 NPC1 (0.33)
SCHEMBL22989004 0.89 TERT (0.32)
SCHEMBL22989208 0.89 MEN1 (0.32)
SCHEMBL22988996 0.88 TERT (0.31)
SCHEMBL22989211 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-02-18 WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 US disclosed